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target cells in terms of relative CD16 + lymphocytes (from p<0,001 and p<0,05). The 
level of CD25 + lymphocytes indicate a probable early cell activation in the all groups 
monitoring and activation of inflammation especially in patients with nonalcoholic 
steatohepatitis with moderate activity (from p<0,001 and p<0,05). It is determines 
that in the both nonalcoholic hepatic steatosis and nonalcoholic steatohepatitis the 
increased level of expression in CD95+ peripheral blood lymphocytes is observed, 
indicating a readiness to cell apoptosis and further progression of nonalcoholic fatty 
liver disease.
Conclusions. The patients with comorbid course of nonalcoholic hepatic steatosis 
and nonalcoholic steatohepatitis in combination with the obesity and pathology 
of biliary tract the authentic increase of the number of the activated receptors on 
lymphocytes is observed (CD16+, CD25+, CD95+) which according to the increase of 
the body mass index which is more significant in the presence of the steatohepatitis.
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Introduction. One of the most common diseases of the cardiovascular system in 
the world is arterial hypertension (AH). Today, the prevention of damage to «target 
organs» is important issue. It is well known that hypertension is associated with the 
development of asymptomatic brain lesions. But not always the control of the blood 
pressure improve symptoms such as headache, dizziness, confusion, fatigue, low 
mood, memory loss. 
Objectives. The aim of our study was to evaluate efficiency of the use of 
ethylmethyl-dyroxypiridine sukcinate in complex therapy in patients with arterial 
hypertension depending on renal function.
Methods. The study included 30 patients (mean age 65,2±6,2 years) with AH. 
Patients included in the study on the background of medicamentous correction of 
AH. To determine the degree of cognitive impairment was used the Montreal scale 
assessment of cognitive impairment (MoCA). To determine the level of disorders in 
psycho-emotional sphere we used the hospital anxiety scale (HADS-T) and hospital 
depression scale (HADS-D). The patients were divided into two groups depending on 
the level of glomerular filtration rate (GFR). The first group (11 persons) consisted 
of patients with AH with preserved renal function (GFR>90ml/min/1,73 m2), in this 
group to «basic» antihypertensive therapy we added ethylmethylhydroxypyridine 
succinate; the second group (10 persons) – patients with AH with reduced renal 
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function (60 ml/min/1,73 m2<GFR<90 ml/min/1,73 m2), in this group we also added 
the ethylmethylhydroxypyridine succinate; and patients in the control group (9 
people) who received only «basic» therapy of AH.
Results. In the beginning of the study the indicators of anxiety and depression 
did not vary significantly in all groups. At the end of the study, the changes in 
the indicators of scales of anxiety and depression demonstrated the reduce the 
severity of anxiety and depressive disorders in groups where patients received 
ethylmethylhydroxypyridine succinate. So in the first group the number of patients 
with subclinical anxiety decreased by 5 (55,56 %) (p<0,05), the second – 5 (62,5 %) 
(p<0,05), control – 2 (22,22 %) (p<0,05). The number of patients with subclinical 
depression in the first group decreased by 4 (is 57,14 %) (p<0,05), the second – 4 
(50 %) (p<0.05) and in the control group – 1 (12,5 %) (p>0.05). More expressed positive 
dynamics was observed among patients who in addition to the standard therapy of 
hypertension patients received the drug containing ethylmethylhydroxypyridine 
succinate. Special attention was paid to dynamics of indicators of MoCA as the most 
sensitive in mild cognitive impairment. By the end of the study showed positive 
trends in main groups: first – +9,12 % (p<0,05), the second +8,92 % (p<0,05), in the 
control and +1,2% (p>0.05), with significantly more expressed dynamics in patients 
who took ethylmethylhydroxypyridine succinate.
Conclusions. Ethylmethylhydroxypyridine succinate demonstrated a compa-
rable efficiency in the studied groups, indicating lack of influence of renal function 
decrease (60 ml/min/1,73 m2<GFR<90 ml/min/1,73 m2) to the clinical efficiency of 
this drug. Ethylmethylhydroxypyridine succinate in addition to the standard therapy 
of arterial hypertension has demonstrated an additional clinical efficiency: positive 
dynamics of indicators of psycho-emotional sphere and MoCA level. 
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The aim of the work: to conduct a comparison of the nature of renal disease 
with the clinical course of hemorrhagic vasculitis (HV), to assess the correlation 
between extrarenal manifestation of disease with morphological features of 
glomerulonephritis (GN).
Materials and methods. The study included 144 patients with HV (56 % 
of men and 44 % of women). In 21 patients (12 men and 9 women) with preserving 
renal function and urinary syndrome it was performed morphological study of renal 
tissuein their lifetime. As a whole, GN was diagnosed in 65 % of patient population, 
chronic renal failure I–IV degree – in 17 %, nephrotic syndrome – in 8 %. The 
morphological class GN was bigger in men.
